Cambrex Reports Rise in Profits and Sales

Cambrex (East Rutherford, NJ) reported a more than doubling in net profits for the first quarter ended March 31, 2012, compared with the year-ago quarter, to $7 million. Net sales for the quarter increased 14%, to $70 million, primarily due to higher sales volumes of controlled substances and generic active pharmaceutical ingredients (APIs), Cambrex says.       The strong sales and profit growth in the first quarter are “driven by most of our product categories,” says Steven M. Klosk, president and CEO of Cambrex...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers